Core Viewpoint - Doubleview Gold Corp. announced the results of its Annual General and Special Meeting, including the approval of its equity incentive plan and the filing of its financial statements for the periods ended November 30, 2025, and August 31, 2025 [1] AGM Results - Shareholders approved the election of all nominees as directors, including the appointment of Christopher Cherry as a new director, who has over 20 years of corporate accounting and audit experience [2] - The appointment of the Company's auditors for the upcoming year was approved, along with authorization for the Board of Directors to fix the auditors' remuneration [3] Equity Incentive Plan - The equity incentive plan proposed by the Company was approved by shareholders as outlined in the management information circular [4] Financial Statements - The Company filed its reviewed financial statements and management discussion for the six-month period ended November 30, 2025, and restated its financial statements for the six-month period ended August 31, 2025, due to errors in the financial information [5] - The restatement was made to ensure compliance with International Financial Reporting Standards (IFRS) and included additional disclosures regarding related parties and subsequent events [5] Company Overview - Doubleview Gold Corp. is a mineral resource exploration and development company based in Vancouver, focusing on precious and base metal projects across North America, particularly in British Columbia [6] - The Company aims to enhance shareholder value through the acquisition and exploration of high-quality projects in critical minerals such as gold, copper, cobalt, scandium, and silver [6] Stakeholder Engagement - The success of Doubleview is attributed to the support of long-term shareholders and institutional investors, which has been crucial for advancing the Company's strategic initiatives [7] - The Company looks forward to collaborative growth and development, encouraging active participation from stakeholders as it expands its portfolio in the critical minerals sector [8]

Apex Critical Metals Announces Grant of Stock Options ELEMENT--[Back to the Newsroom]# Apex Critical Metals Announces Grant of Stock OptionsVANCOUVER, BC / [ACCESS Newswire]/ February 2, 2026 / Apex Critical Metals Corp. (CSE:APXC)(OTCQX:APXCF)(FWB:KL9) ("Apex" or the "Company"), a Canadian mineral exploration company focused on the identification and development of critical and strategic metals, is pleased to announce that it has granted (the "Grant") an aggregate of 200,000 incentive stock options (each, ...

Core Viewpoint - Lomiko Metals Inc. has announced the grant of Restricted Share Units (RSUs) and Deferred Share Units (DSUs) to its management and board as part of its annual incentive program, aligning compensation with long-term objectives [1][3]. Compensation Details - The Board approved the grant of a total of 411,095 RSUs and 731,953 DSUs to the Company's directors, while management received 425,133 RSUs and 50,000 stock options [2]. - RSUs will vest by January 22, 2027, calculated based on a 5-day volume weighted average closing price of C$0.15 per common share [4]. - DSUs for directors will also vest on January 22, 2027, and are settled upon retirement from the board, similarly calculated using the same share price [5]. - Management's stock options have a 5-year term with a vesting schedule of one-third on the grant date, the first anniversary, and the third anniversary, with an exercise price of C$0.15 per option [6]. Stock Options Cancellation - The board has cancelled a total of 355,000 stock options with an exercise price of C$1.20 to increase available capacity under the Plan [7]. Company Overview - Lomiko Metals holds mineral interests in the La Loutre graphite development in southern Quebec, covering 4,528 hectares [8]. - The La Loutre project is located within the territory of the Kitigan Zibi Anishinabeg First Nation and is 180 kilometers northwest of Montreal [8]. Mineral Resource Estimate - An updated Mineral Resource Estimate for the La Loutre Project reported 64.7 million tonnes of Indicated Mineral Resources averaging 4.59% Cg per tonne, representing a 184% increase in tonnage [10]. - The increase in Indicated Mineral Resources was attributed to a 2022 drilling campaign, which added 41.5 million tonnes compared to the 2021 estimate [10][11]. Additional Projects - The Company also has interests in seven early-stage projects in southern Quebec, covering 328 claims and totaling 18,622 hectares [12].

Core Viewpoint - OneConstruction Group Limited reported a slight decrease in revenue and a net loss for the six months ended September 30, 2025, primarily due to increased administrative expenses and a decline in private sector revenue. Financial Performance - Revenue decreased by 3.4% from $28.7 million for the six months ended September 30, 2024, to $27.8 million for the same period in 2025, attributed to a decline in private sector revenue amidst a slowdown in the commercial property market in Hong Kong [2] - Net loss for the six months ended September 30, 2025, amounted to $0.1 million, compared to a net income of $1.2 million for the same period in 2024, mainly due to increased administrative expenses and share-based payment expenses [5] - Basic and diluted loss per share were $0.008 for the six months ended September 30, 2025, compared to earnings per share of $0.11 for the same period in 2024 [6] Administrative Expenses - Administrative expenses increased by 94.9% from $0.9 million for the six months ended September 30, 2024, to $1.7 million for the same period in 2025, driven by higher professional fees, payroll increases due to headcount growth, and increased leasing expenses [3] Share-Based Payment - OneConstruction Group established a 2025 Equity Incentive Plan, authorizing 3,000,000 Ordinary Shares for issuance to attract and retain personnel, resulting in share-based payment expenses during the reporting period [4] Liquidity and Capital Resources - As of September 30, 2025, OneConstruction Group had cash of $4.8 million, total current assets of $49.3 million, and total current liabilities of $14.5 million, resulting in net current assets of $34.8 million and a current ratio of 3.4 [7] Balance Sheet Overview - Total assets as of September 30, 2025, were $50.0 million, with total liabilities of $37.3 million, leading to shareholders' equity of $12.7 million [7]

Group 1 - The company has granted a total of 1,200,000 stock options at a price of $3.71 per option share to Directors, Officers, and Consultants [1] - Shareholders approved a new omnibus equity incentive plan to replace the existing stock option plan, which allows for the grant of various types of incentive securities while limiting the total number of outstanding incentive securities to 10% of the issued and outstanding common shares [2] - The number of directors has been fixed at four, and all standing directors were elected for the upcoming year, along with the re-appointment of the company's auditors [3] Group 2 - Kirkstone Metals Corp. is a Canadian mineral exploration company focused on uranium exploration within established mining jurisdictions in Canada [3]

Core Points - Neurothera Labs Inc. held its annual and special meeting of shareholders on January 8, 2026, where key decisions were made regarding the company's governance and future plans [1] Group 1: Shareholder Decisions - All nominee directors listed in the management information circular dated December 4, 2025, were elected as directors [2] - Shareholders voted to appoint Dale Matheson Carr-Hilton Labonte LLP as auditors for the upcoming year and authorized the directors to fix their remuneration [2] - A consolidation of common shares was authorized, allowing for a potential consolidation of one post-consolidation share for up to one hundred pre-consolidation shares, subject to the directors' discretion and market conditions [3] - The adoption of a 20% fixed equity incentive plan was approved, pending final approval from the TSX Venture Exchange [4] Group 2: Company Overview - Neurothera Labs Inc. is a clinical-stage pharmaceutical company focused on developing novel therapeutics for central nervous system disorders and other underserved health conditions through collaborations and innovative combinations [5]

Core Points - Clean Seed Capital Group Ltd. held its annual general meeting on January 7, 2026, where key decisions were made regarding the company's governance and financial strategies [1] Group 1: Election of Directors - Graeme Lempriere, Gary Anderson, Glenn Gatcliffe, and Dr. Ulrich Trogele were re-elected as directors of the company [2] Group 2: Appointment of Auditor - MNP LLP was reaffirmed as the auditor for the company for the upcoming year [3] Group 3: Equity Incentive Plan - A new equity incentive plan was approved, allowing the company to grant stock options up to 10% of its issued and outstanding shares and other equity awards capped at 11,154,127 shares [4][5] Group 4: New Control Person - The company announced a shares-for-debt transaction totaling $1,000,000 with insider Jason Schultz, who will receive 5,500,000 shares, resulting in him holding over 20% of the outstanding shares on a partially diluted basis [6][8] Group 5: Shares for Debt - The issuance of 5,500,000 common shares to settle non-cash debts related to lease, equipment rental costs, and advisory fees was approved by disinterested shareholders [9][10] Group 6: Company Overview - Clean Seed is an agricultural technology company focused on the commercialization of its SMART Seeder™ technologies, which aim to reduce fertilizer usage while enhancing crop performance [11][12]

Core Viewpoint - Salesforce has granted equity awards to new employees as part of its acquisition of Regrello, under its 2014 Inducement Equity Incentive Plan, highlighting its commitment to integrating new talent into the organization [1][2]. Group 1: Equity Awards - A total of 222,453 restricted stock units (RSUs) were granted to 55 employees at Regrello [2]. - The RSUs will vest over a four-year period, with 25% vesting on the first anniversary of the grant date and the remaining balance vesting quarterly in 12 equal installments [2]. - All equity awards are contingent upon the employees' continued service through each applicable vesting date, and all recipients are non-executive officers [2]. Group 2: Company Overview - Salesforce positions itself as the leading AI CRM provider, aiming to help organizations of any size become agentic enterprises by integrating humans, agents, apps, and data on a unified platform [3].

Core Viewpoint - Hong Kong Pharma Digital Technology Holdings Limited (HKPD) successfully passed all proposals at its 2025 annual meeting, indicating a strategic shift and governance updates for the company [1][2][3]. Group 1: Shareholder Proposals - Proposal No. 1 involved the re-election of five directors to serve until the 2026 Annual Meeting [1]. - Proposal No. 2 ratified the appointment of Onestop Assurance PAC as the independent registered public accounting firm for the fiscal year ending March 31, 2026 [1]. - Proposal No. 3 increased the authorized share capital from US$100,000 to US$1,000,000, allowing for a total of 1,000,000,000 ordinary shares [1]. Group 2: Share Structure Changes - Proposal No. 4 re-designated and re-classified the company's shares into Class A and Class B ordinary shares [2]. - Proposal No. 5 approved a Reverse Share Split and Share Consolidation of the company's issued and outstanding ordinary shares [2]. Group 3: Corporate Identity and Governance - Proposal No. 6 changed the company's name to "Cellyan Biotechnology Co., Ltd" and its foreign name to "生研生物公司" [3]. - Proposal No. 7 adopted the fourth amended and restated memorandum and articles of association [3]. - Proposal No. 8 involved the repurchase of 7,150,000 Class A Ordinary Shares and the issuance of Class B Ordinary Shares [3]. - Proposal No. 9 approved the 2025 Equity Incentive Plan [3]. Group 4: Company Overview - HKPD specializes in OTC pharmaceutical cross-border e-commerce supply chain services through its subsidiary, Joint Cross Border Logistics Company Limited [4]. - The company also engages in OTC pharmaceutical cross-border procurement and distribution via its subsidiary, V-Alliance Technology Supplies Limited [4]. - Joint Cross Border provides a comprehensive service offering, including product procurement, logistics, and delivery for Mainland Chinese customers seeking OTC pharmaceutical products [5][6].

Core Points - The company, Cypherpunk Technologies, Inc., formerly known as Leap Therapeutics, Inc., held a virtual Special Meeting of Stockholders on December 15, 2025 [1] - The meeting agenda included several proposals for stockholder approval [2] Proposal Summaries - A proposal to amend the company's Certificate of Incorporation to increase the total number of shares from 250 million to 500 million, with 490 million designated as common stock [3] - A proposal to authorize the Board to amend the Certificate of Incorporation for a reverse stock split at a ratio between 1:5 and 1:20, to be executed at the Board's discretion within one year [4] - A proposal to adopt a new 2025 Equity Incentive Plan [4] - A proposal to allow the company to issue shares exceeding 19.99% of the outstanding common stock to comply with NASDAQ listing rules upon the exercise of certain warrants [5]